Gynius
The computed 12-month bankruptcy probability of Gynius is 0.2% (very low). The 2025 annual accounts show equity of €39k and a net result of €116k. Equity is growing by ~34.5% per year across the filed fiscal years. Its solvency ranks better than 22% of 2187 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €39k |
| Net result | €116k |
| Better than sector | 22% |
| Active | 5 yrs |
Strong profile, led by profitability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 9.7% | 58.1% | |
| Net result | €116k | €60k | |
| Equity | €39k | €74k | |
| Gross operating margin | €171k | €96k | |
| Total assets | €400k | €186k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €171k |
| Net profit | €116k |
| Cash flow | €129k |
| Staff costs | - |
| Income taxes | €35k |
| Dividends | €293k |
| Total assets | €400k |
| Equity | €39k |
| Debt | €361k |
| of which ≤ 1y | €323k |
| of which > 1y | €32k |
| Working capital | €34k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 1.10 |
| Quick ratio | 1.10 |
| Working capital ratio | 8.4% |
| Solvency | 9.7% |
| Debt / equity | 9.36 |
| Long-term debt ratio | 0.82 |
| Interest coverage | 19.96 |
| Gross margin | - |
| Net margin | - |
| ROA | 29.1% |
| ROE | 301.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €400k |
| Fixed assets | 21/28 | €43k |
| Tangible fixed assets | 22/27 | €43k |
| Financial fixed assets | 28 | €200 |
| Current assets | 29/58 | €357k |
| Amounts receivable within one year | 40/41 | €913 |
| Cash & bank | 54/58 | €320k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €400k |
| Equity | 10/15 | €39k |
| Contributions / capital | 10/11 | €7k |
| Reserves | 13 | €32k |
| Amounts payable | 17/49 | €361k |
| Amounts payable after one year | 17 | €32k |
| Amounts payable within one year | 42/48 | €323k |
| Trade debts payable within one year | 44 | €5k |
| Income statement | ||
| Gross operating margin | 9900 | €171k |
| Operating result | 9901 | €158k |
| Financial income | 75 | €2k |
| Financial charges | 65 | €9k |
| Result before taxes | 9903 | €151k |
| Income taxes | 67/77 | €35k |
| Net result for the period | 9904 | €116k |
| Result to be appropriated | 9905 | €116k |
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 28-10-2020 |
| Status | Active |
| Postal code | 3500 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71052D0045/00K000 | Flanders | 3,742 m² | 1 · 386 m² | 14.3 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
02-06-2023 Registered office moved to Hasselt
- Siegersveldstraat 32, 3500 Hasselt
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": null,
"city": "Hasselt",
"region": "vlaams_gewest",
"street": "Siegersveldstraat",
"country": "BE",
"postcode": "3500",
"box_number": null,
"street_number": "32",
"locality_suffix": "(Sint-Lambrechts-Herk)"
},
"old_address": null,
"effective_date": null,
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "inferred",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "not_specified",
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Stefan Vangoetsenhoven",
"firm_city": null,
"firm_name": null,
"office_city": "Bertem",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-06-02",
"filing_date": "2023-05-31",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2023-05-17",
"unanimous": true
},
"subject_company": {
"kbo": "0757.559.310",
"name_full": null,
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Stefan Vangoetsenhoven",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Gynius |